Federal workers get lower drug costs; drug plan managers must show rebates.

What it does

This bill changes how drug plan managers pay for drugs for federal workers. Drug plan managers must pay stores based on what drugs cost. They must give rebates from drug makers to patients right away. Drug plan managers cannot push patients to their own stores. The bill sets fines up to $10,000 per broken rule. The cap is $100,000 per drug plan manager per firm per ten years.

Who it affects

Federal workers and retirees pay less because rebates go to them at the store. Small drug stores and chains may fill more prescriptions. Drug plan managers lose hidden profits from rebates and pushing patients.

One thing to notice

The bill only covers federal workers. State health plans are not covered, so most people do not get these rules.

From the analysis of the bill text, linked under Primary records below.

Where it stands

42 cosponsors: 24 Republicans, 18 Democrats.

• Dec 11, 2025 — Introduced · Congress.gov: “Introduced in House”
• Dec 11, 2025 — Referred to House Committee on Oversight and Government Reform · Congress.gov: “Referred to the House Committee on Oversight and Government Reform”
• Jul 22, 2026 — Markup held in committee · Congress.gov: “Committee Consideration and Mark-up Session Held”
• Jul 22, 2026 — Reported out of committee · Congress.gov: “Ordered to be Reported (Amended) by the Yeas and Nays: 40 - 2”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

11 groups reported lobbying about this bill. They filed 15 reports from Dec 2025 to Jun 2026.

Those reports show $19,632,656 in lobbying spending. Each report lists about 20 bills. So that money was not all for this bill.

More groups named this bill than 92% of bills with any report.

Jake Auchincloss, who sponsored the bill, received $740,250 from PACs for the 2026 election.

• Pharmaceutical Research and Manufacturers of America — $7,360,000 in 1 report
• Pharmaceutical Care Management Association — $6,472,656 in 2 reports
• CVS Health (and Subsidiaries) — $3,570,000 in 1 report
• Gsk (fka Glaxosmithkline Inc.) — $890,000 in 1 report
• National Treasury Employees Union — $690,000 in 2 reports

Lobbying is legal. These reports show who lobbied about this bill, not what changed.

Words to know

• rebates — Money that drug makers pay back to drug plan managers for selling their drugs.
• lobbying — Trying to influence lawmakers about a bill. Companies and groups pay people to do this.
• PACs — Groups that collect money and give it to candidates for office.
• sponsored — To sponsor a bill is to introduce it in Congress and put your name on it.